vaccines and immunisation
The use of supplementary immunisation activities to improve uptake of current and future vaccines in low income and middle income countries : a systematic review protocol
... of immunisation services in obtaining optimal vaccination ...new vaccines continue to be incorporated in the existing Expanded Programme on Immunisation, 22 23 adding more logistical and fi nancial ...
8
Intranasal immunisation with recombinant adenovirus vaccines protects against a lethal 2 challenge with pneumonia virus of mice
... human respiratory syncytial virus elicits protective immunity in BALB/c mice... immunization with chimpanzee adenovirus expressing RSV fusion protein protects against.[r] ...
33
Global health initiative investments and health systems strengthening: a content analysis of global fund investments
... The Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), the Global Alliance for Vaccines and Immunisation (GAVI), and the President ’ s Emergency Plan for AIDS Relief (PEP[r] ...
14
STUDENTS’ CORNER NARRATIVE REVIEW Rotavirus vaccine — a new hope
... vaccine significantly reduced the infant mortality rate (IMR) in Sudan (Figure-2) while no significant decrease in IMR was seen in Ethiopia where Rotavirus vaccine was not introduced (Figure-3). According to another ...
6
Kalies, Helen (2007): Invasive Haemophilus influenzae type b disease in German children: epidemiology and vaccine effectiveness in the era of hexavalent vaccines. Dissertation, LMU München: Medizinische Fakultät
... hexavalent vaccines; of these, 5 received an incomplete primary series, 5 received the full primary series and none a 2 nd year dose or the full immunisation before ...
93
Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011
... HIV vaccines and ...of vaccines and ...novel immunisation strategies; microbicides and PrEP (alone and in combination with vaccines); mucosal transmission of HIV/SIV; mucosal vaccination; ...
14
Prevention of hepatitis A and B by immunisation
... Another mammalian cell derived vaccine (Chinese hamster ovary cells, OHO cells) containing S, pre-S 1 and pre-82 antigens was shown recently to induce seroconversion rates similar to the two currently licensed S antigen ...
198
An ethical framework for public health immunisation programs
... Most vaccines are given to a large population of mainly healthy individuals, so large numbers of individuals may be affected by rare adverse ...of vaccines and indeed of the whole program, including the way ...
5
An evaluation of South Africa’s public–private partnership for the localisation of vaccine research, manufacture and distribution
... of vaccines required by the South African National Department of Health for its immunisation programme, the net value of which was ...of vaccines and the ability to respond quickly to vaccine ...
17
Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations
... passive immunisation should be considered for an unvaccinated patient or a patient with insufficient response exposed to ...gov/ vaccines/ pubs/ pinkbook/ downloads/ ...
27
Development of DNA vaccines against Burkholderia pseudomallei
... DSTO-TN-08n 3.3 Immunisation and challenge of mice with multiple DNA vaccine constructs Based on the results observed following immunisation with a single DNA vaccine construct, the four[r] ...
32
In Search of Factors Negatively Affecting Vaccine Immunity to Pertussis in Preschool Children Before the Administration of the First Booster
... primary immunisation, both during epidemics and years without epidemics, the risk of getting pertussis was lower in children vaccinated with DTwP than in those vaccinated with ...whole-cell vaccines were ...
24
From Immunology to Social Policy: Epistemology and Ethics in the creation and administration of paediatric vaccines
... paediatric vaccines simultaneously, because it implies care should be taken to ensure, as far as possible, that the adjuvants used in one vaccine will not interfere with the immune response to the other ...
373
Evaluation of the Safety and Protection E cacy of spiC and nmpC or rfaL Deletion Mutants of Salmonella Enteritidis as Live Vaccine Candidates for Poultry Non-Typhoidal Salmonellosis
... SpiC is an SPI-2-encoded effector protein that is secreted by SPI-2 type III secretion system (T3SS) of Salmonella into macrophages [12]. Deletion of spiC has been confirmed to significantly reduce Salmonella virulence ...
13
Assessing Vaccine Hesitancy among Healthcare Workers: A Cross-Sectional Study at an Italian Paediatric Hospital and the Development of a Healthcare Worker’s Vaccination Compliance Index
... This survey shows that vaccine hesitancy issues exist and are relevant in the investigated hospital, with substantial differences between departments and professional classes. The departments most affected by this ...
15
Considering Genomic and Immunological Correlates of Protection for a Dengue Intervention
... tetravalent vaccines also in development, all of which contain regions of the DENV proteome known to elicit robust antibody responses ...these vaccines raises the question of how you can ensure each ...
20
E ect of Di erent Adjuvants on the Longevity and Strength of Humoral and Cellular Immune Responses to the HCV Envelope Glycoproteins
... these vaccines could induce both cytotoxic and humoral immune responses targeting HCV despite the lack of a detectable E1/E2-specific CD8 responses in our ...
16
The Use of Analgesics during Vaccination with a Live Attenuated Yersinia pestis Vaccine Alters the Resulting Immune Response in Mice
... These data should also be discussed in the context of administering analgesics during the challenge phase of vaccine studies. There are several examples where the potency of vaccines is increased because the ...
28
Yellow Fever Virus Genotyping Tool and Investigation of Suspected Adverse Events Following Yellow Fever Vaccination
... We used this tool to investigated adverse events following Yellow fever vaccination, after a mass vaccine campaign in Minas Gerais.. We solved 17 suspected adverse events following YF va[r] ...
10
Simultaneous Deletion of Virulence Factors and Insertion of Antigens into the Infectious Laryngotracheitis Virus Using NHEJ-CRISPR Cas9 and Cre–Lox System for Construction of a Stable Vaccine Vector
... After successful demonstration that marker genes could be inserted in the target site of the ILTV genome and the corresponding genes can be deleted from the backbone of ILTV by CRISPR/Cas9 technology, we aimed to ...
15